1300 related articles for article (PubMed ID: 10411935)
1. CpG island methylator phenotype in colorectal cancer.
Toyota M; Ahuja N; Ohe-Toyota M; Herman JG; Baylin SB; Issa JP
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8681-6. PubMed ID: 10411935
[TBL] [Abstract][Full Text] [Related]
2. CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci.
Kawasaki T; Ohnishi M; Nosho K; Suemoto Y; Kirkner GJ; Meyerhardt JA; Fuchs CS; Ogino S
Mod Pathol; 2008 Mar; 21(3):245-55. PubMed ID: 18204436
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.
Toyota M; Ahuja N; Suzuki H; Itoh F; Ohe-Toyota M; Imai K; Baylin SB; Issa JP
Cancer Res; 1999 Nov; 59(21):5438-42. PubMed ID: 10554013
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
[TBL] [Abstract][Full Text] [Related]
5. Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer.
Wong JJ; Hawkins NJ; Ward RL; Hitchins MP
Mod Pathol; 2011 Mar; 24(3):396-411. PubMed ID: 21102416
[TBL] [Abstract][Full Text] [Related]
6. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer "methylator phenotype": fact or artifact?
Anacleto C; Leopoldino AM; Rossi B; Soares FA; Lopes A; Rocha JC; Caballero O; Camargo AA; Simpson AJ; Pena SD
Neoplasia; 2005 Apr; 7(4):331-5. PubMed ID: 15967110
[TBL] [Abstract][Full Text] [Related]
8. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability.
Kim H; Kim YH; Kim SE; Kim NG; Noh SH; Kim H
J Pathol; 2003 May; 200(1):23-31. PubMed ID: 12692837
[TBL] [Abstract][Full Text] [Related]
9. Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer.
Deng G; Peng E; Gum J; Terdiman J; Sleisenger M; Kim YS
Br J Cancer; 2002 Feb; 86(4):574-9. PubMed ID: 11870540
[TBL] [Abstract][Full Text] [Related]
10. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH
Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226
[TBL] [Abstract][Full Text] [Related]
11. APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer.
Iacopetta B; Grieu F; Li W; Ruszkiewicz A; Caruso M; Moore J; Watanabe G; Kawakami K
Int J Cancer; 2006 Nov; 119(10):2272-8. PubMed ID: 16981189
[TBL] [Abstract][Full Text] [Related]
12. CpG island methylation in colorectal adenomas.
Rashid A; Shen L; Morris JS; Issa JP; Hamilton SR
Am J Pathol; 2001 Sep; 159(3):1129-35. PubMed ID: 11549606
[TBL] [Abstract][Full Text] [Related]
13. CpG island methylator phenotypes in aging and cancer.
Toyota M; Issa JP
Semin Cancer Biol; 1999 Oct; 9(5):349-57. PubMed ID: 10547343
[TBL] [Abstract][Full Text] [Related]
14. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype.
Toyota M; Ohe-Toyota M; Ahuja N; Issa JP
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):710-5. PubMed ID: 10639144
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans.
Ashktorab H; Smoot DT; Farzanmehr H; Fidelia-Lambert M; Momen B; Hylind L; Iacosozio-Dononue C; Carethers JM; Goel A; Boland CR; Giardiello FM
Int J Cancer; 2005 Oct; 116(6):914-9. PubMed ID: 15856472
[TBL] [Abstract][Full Text] [Related]
16. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.
Kim KM; Lee EJ; Ha S; Kang SY; Jang KT; Park CK; Kim JY; Kim YH; Chang DK; Odze RD
Am J Surg Pathol; 2011 Sep; 35(9):1274-86. PubMed ID: 21836485
[TBL] [Abstract][Full Text] [Related]
17. Genetics supersedes epigenetics in colon cancer phenotype.
Yamashita K; Dai T; Dai Y; Yamamoto F; Perucho M
Cancer Cell; 2003 Aug; 4(2):121-31. PubMed ID: 12957287
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of DNA methylation status analyzed by bisulfite-PCR-SSCP and correlation with clinico-pathological characteristics in colorectal cancer.
Maekawa M; Sugano K; Ushiama M; Fukayama N; Nomoto K; Kashiwabara H; Fujita S; Kakizoe T
Clin Chem Lab Med; 2001 Feb; 39(2):121-8. PubMed ID: 11341745
[TBL] [Abstract][Full Text] [Related]
19. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression.
Deng G; Chen A; Hong J; Chae HS; Kim YS
Cancer Res; 1999 May; 59(9):2029-33. PubMed ID: 10232580
[TBL] [Abstract][Full Text] [Related]
20. The epigenetics of colorectal cancer.
Issa JP
Ann N Y Acad Sci; 2000 Jun; 910():140-53; discussion 153-5. PubMed ID: 10911911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
